BSF 208075

· Gilead Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BSF 208075, covering 2009-04-16 to 2009-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Study of BSF 208075 Evaluating Exercise Capacity in Patients With Pulmonary Arterial Hypertension [Phase 2]